Study guide

15.3 Acquisition, Positioning, and Image Quality

Certified Nuclear Medicine Technologist CNMT

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current CNMT Exam Facts 1.2 How to Use This Guide

2 Radiation Physics Fundamentals

2.1 Radioactive Materials, Isotopes, and Decay Modes 2.2 Decay Calculations and Counting Statistics 2.3 Interactions of Radiation with Matter 2.4 Radiation Detector Types and Principles

3 Biological Effects & ALARA

3.1 Biological Effects of Radiation Exposure 3.2 ALARA and Protection Calculations 3.3 Dose Limits, Surveys, and Personal Monitoring

4 NRC & Regulatory Compliance

4.1 NRC Areas, Spills, Waste, and Records 4.2 Written Directives and DOT Shipping 4.3 EPA, OSHA, HIPAA, FDA, and USP Standards 4.4 Radioactive Waste Disposal and Regulatory Records

5 Generators & Kit Preparation

5.1 Radionuclide Generators and Quality Control 5.2 Radiopharmaceutical Kit Preparation 5.3 Radiopharmaceutical Quality Control

6 Tc-99m Diagnostic Agents

6.1 Tc-99m Cardiac Imaging Agents 6.2 Tc-99m Bone, Renal, and GU Agents 6.3 Tc-99m GI and Hepatobiliary Agents 6.4 Tc-99m CNS, Infection, and Labeled Cells

7 Non-Tc Diagnostic & PET Agents

7.1 Iodine and Indium Diagnostic Agents 7.2 Gallium, Thallium, Xenon, and Miscellaneous Agents 7.3 PET Radiopharmaceuticals 7.4 Neurologic, Breast, and Neuroendocrine PET Agents

8 Therapeutics, Adjuncts & Administration

8.1 Therapeutic Radiopharmaceuticals 8.2 Interventional and Adjunct Pharmaceuticals 8.3 Blood Labeling and Administration Techniques 8.4 Blockade, Comfort, and Gastrointestinal Adjunct Agents

9 Non-Imaging Instrumentation

9.1 Well Counters, Probes, and Survey Meters 9.2 Dose Calibrator Quality Control 9.3 Auxiliary and Patient Care Equipment

10 Imaging Systems & Quality Control

10.1 Gamma Camera Quality Control 10.2 SPECT and SPECT/CT Systems 10.3 PET and PET/CT Systems and QC 10.4 CT Systems, PACS, and Information Systems 10.5 CT Radiation Dose, Safety Alerts, and Protocol Optimization

11 Pulmonary, Bone, Oncology & Infection Imaging

11.1 Pulmonary Imaging Procedures 11.2 Bone and Musculoskeletal Imaging 11.3 Oncology Imaging Procedures 11.4 Infection Imaging Procedures

12 Renal, Endocrine & Hematopoietic Imaging

12.1 Renal and Genitourinary Imaging 12.2 Endocrine Imaging (Thyroid, Parathyroid, Adrenal) 12.3 Hematopoietic and Bone Marrow Imaging 12.4 Thyroid Uptake Measurement and Radioiodine Survey Technique

13 Cardiovascular Procedures

13.1 Myocardial Perfusion Imaging 13.2 Cardiac Function, Viability, and Special Studies 13.3 Exercise and Pharmacologic Stress Testing

14 GI, CNS, Therapy & Hybrid CT Procedures

14.1 Gastrointestinal Procedures 14.2 Central Nervous System Procedures 14.3 Radionuclide Therapy Procedures 14.4 CT and Hybrid Imaging in Nuclear Medicine 14.5 CSF Studies: Cisternography, Leak Localization, and Shunt Patency

15 Patient Care & Clinical Workflow

15.1 Patient Care, Education, and Consent 15.2 Scheduling and Radiopharmaceutical Procurement 15.3 Acquisition, Positioning, and Image Quality 15.4 Image Processing and Quantitative Analysis 15.5 Non-Imaging Studies: Specimens, Counting, and Error Analysis

15.3 Acquisition, Positioning, and Image Quality

Key Takeaways Explain This Topic AI

Correct positioning, anatomical markers, and immobilization reduce motion artifact and laterality errors; label right/left and injection sites when protocol requires.

Acquisition parameters—matrix, time/counts, energy window, collimator, orbit, and zoom—must match the clinical question and photon energy.

Technologists evaluate images at a technical level for completeness, count density, motion, and obvious artifacts before releasing the patient; know when to repeat or add views.

SPECT/CT and PET/CT require accurate co-registration; CT misalignment, truncation, and metal can create attenuation-correction artifacts that mimic disease.

Before administration: reconcile patient identity with RP label, calculate volume for the prescribed activity from assayed concentration, and use the ordered route/technique (IV bolus vs infusion, oral, inhalation).

Last updated: August 2026

15.3 Acquisition, Positioning, and Image Quality

Quick Answer: Reconcile patient ↔ RP ↔ order , calculate the correct volume , administer by the ordered route , then acquire with correct collimator, energy window, matrix, time/counts, and positioning . Spot artifacts early, fix SPECT/CT–PET/CT registration , and repeat or add views when the study is incomplete or non-diagnostic.

Image quality is a technologist product. Physicians interpret disease; technologists deliver technically adequate, correctly labeled, artifact-controlled datasets. Domain V acquisition items often present a flawed image description and ask what went wrong—or what to do next before releasing the patient.

Patient / RP Reconciliation and Volume Calculation

Before administration , perform a final three-way check:

  • Patient identity (two identifiers)
  • Radiopharmaceutical label (agent, activity, calibration time, expiration, route)
  • Order / protocol (study type, prescribed dosage range)

Assay the dose in the dose calibrator (or verify unit-dose assay) and apply decay correction to administration time. If concentration is known: Volume (mL) = Prescribed activity Concentration (activity/mL) \text{Volume (mL)} = \frac{\text{Prescribed activity}}{\text{Concentration (activity/mL)}} Volume (mL) = Concentration (activity/mL) Prescribed activity ​

Account for residual in the syringe after injection when residual activity matters for quantification or therapy records. Never administer outside the prescribed range without authorized adjustment. If the assayed activity is outside the ordered window after decay correction, stop—redraw, reorder, or obtain authorized user direction rather than “close enough” injection.

Administration Route and Technique

  • Route Technique keys
  • IV Patent access; avoid infiltrate; flush per protocol; note site for markers
  • Bolus Tight bolus for first-pass/flow studies; arm position consistent
  • Infusion Pump rates for pharmacologic stress or certain therapies as ordered
  • Oral Capsule integrity; NPO rules; document time of ingestion
  • Inhalation Seal, breathing pattern, xenon trap / exhaust systems
  • Intrathecal / other special Physician-performed; tech supports sterile field and imaging timing

Infiltrate destroys quantification (renogram, GFR, gastric emptying curves) and may require re-injection decisions by the authorized user. Document and image the site when helpful.

Positioning, Markers, and Immobilization

Align anatomy to protocol: supine vs upright (gastric emptying), arms up for torso SPECT/PET when tolerated, head immobilized for brain SPECT/PET.

Place anatomical markers (cod liver oil capsules, point sources, electronic markers) for laterality, landmarks, or injection sites per lab SOP.

Use straps, head holders, and knee supports to reduce motion— never force a painful position that guarantees motion or injury.

Remove attenuating objects: jewelry, ECG leads when possible, thick clothing zippers, external metal.

Imaging Parameters

  • Parameter Effect on image
  • Collimator LEHR/LEAP for Tc-99m; medium/high energy for Ga-67, I-131, In-111 as appropriate
  • Energy window Centered on photopeak(s); wrong window loses counts or admits scatter
  • Matrix Finer matrix → better potential detail, needs more counts; coarser for low-count studies
  • Time / counts Information density; premature stop → noisy non-diagnostic images
  • Zoom / orbit SPECT radius as close as safe; 360° vs 180° cardiac orbits per protocol
  • Gating ECG quality for MUGA/MPI; bad gating → wall-motion errors

Match parameters to photon energy and clinical question . Using a low-energy collimator for I-131 is a classic artifact factory (septal penetration). Multi-peak radionuclides (e.g., Ga-67, In-111) need all protocol windows enabled—missing a peak silently starves counts.

Normal vs Abnormal Patterns at the Technologist Level

Technologists are not the final interpreters, but they must recognize technical completeness and gross unexpected findings that require extra views or urgent physician notification (e.g., obvious injection failure, missing organ in field of view, severe motion, empty syringe residual suggesting total infiltrate).

  • Check Action if failed
  • Correct body part / FOV Reposition; add views
  • Count density adequate Extend time or repeat
  • Motion Repeat sequence
  • Laterality labeled Correct labels before archive
  • Hybrid alignment Re-register or repeat CT segment per protocol
  • Artifacts and Causes (High-Yield)
  • Artifact Common cause
  • Motion blur / streaks Patient movement, free-breathing mismatch
  • Hot spots on skin Contamination (urine, saliva, injection drip)
  • Cold defects from metal Pacemaker, jewelry, orthopedic hardware on attenuation map
  • Truncation artifact Arms-down CT FOV too small on SPECT/CT or PET/CT
  • Misregistration Patient shifted between emission and CT
  • Photomultiplier / crystal issues Camera QC failures—do not image clinically
  • Wrong collimator / window Septal penetration, low counts, scatter
  • Attenuation without correction Soft-tissue (breast, diaphragm) on SPECT MPI

Contamination hunt: if an unexpected focus appears, survey gown/table/skin and re-image after cleaning when appropriate.

Co-registration: SPECT/CT and PET/CT

Hybrid systems use CT for anatomy and attenuation correction . Co-registration errors create false hot/cold regions—especially near diaphragm, head/neck, and extremities.

Tech responsibilities: instruct breath-hold or free-breathing protocols consistently; minimize table shifts; verify overlay before finalizing reconstruction; flag metal and contrast that distort attenuation maps. When AC images look non-physiologic, review non-AC images—an exam favorite troubleshooting step. Arm position must match between emission and CT whenever the protocol allows; arms-down CT with arms-up PET/SPECT is a common self-inflicted misregistration.

When to Repeat or Add Views

Repeat or add views when:

  • Motion, low counts, or wrong FOV make the study non-diagnostic
  • Suspected contamination vs true lesion needs confirmation
  • Protocol requires post-void, delayed, oblique, or spot views not yet obtained
  • SPECT shows edge-of-FOV truncation of the organ of interest

Do not repeat unlimited times for minor cosmetic issues after a diagnostic dataset is secured—ALARA and schedule reality matter. Escalate ambiguous cases to the supervising physician.

Bottom line: quality chain = right patient/dose/volume/route → right geometry/parameters → artifact control → hybrid registration → know when to fix before the patient leaves .